MDXHEALTH SA has a total of 35 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are LEICA BIOSYSTEMS NEWCASTLE LTD, SIMEG LTD and SYNERGENZ BIOSCIENCE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | United States | 9 | |
#3 | Canada | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Van Criekinge Wim | 19 |
#2 | Trooskens Geert | 8 |
#3 | Vandersmissen Johan | 7 |
#4 | Bovie Catherine | 5 |
#5 | Otto Gaetan | 5 |
#6 | Louwagie Joost | 4 |
#7 | Clark James | 4 |
#8 | Renard Isabelle | 3 |
#9 | Meijer Gerrit A | 3 |
#10 | Carvalho Beatriz | 3 |
Publication | Filing date | Title |
---|---|---|
EP3596236A1 | Mgmt epigenetic deep-sequencing assay | |
AU2014217518A1 | Methods and kits for identifying and adjusting for bias in sequencing of polynucleotide samples | |
EP2912195A2 | Methylation markers predictive for drug response | |
WO2013084075A2 | Methods of detecting mutations and epigenetic changes | |
EP2394170A2 | Methods of detecting colorectal cancer | |
EP2250287A2 | Detection and prognosis of lung cancer |